Summary
A possible pharmacokinetic interaction between theophylline and repirinast has been investigated in asthmatic patients. The kinetics of theophylline was studied in seven adult in-patients given theophylline 400–800 mg b.d. alone and after three weeks of co-administration of repirinast.
There was no effect on the kinetics of the combined treatment.
References
Jenne JW, Wyze E, Rood FS, MacDonald FM (1972) Pharmacokinetics of theophylline: Application to adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther 13: 349–360
Mitenko PA, Ogilvie RI (1973) Rational intravenous doses of theophylline. N Engl J Med 289: 600–603
Levy G, Koysooko R (1975) Pharmacokinetic analysis of the effect of theophylline on pulmonary function in asthmatic children. J Pediatr 86: 789–793
Hendeles L, Bighley L, Richardson RH, Helper CD, Carmichael J (1977) Frequent toxicity from IV aminophylline infusions in critically ill patients. Drug Intell Clin Pharm 11: 12–18
Yarnell PR, Nai-Shin C (1975) Focal seizures and aminophylline. Neurology 25: 819–822
Burkle WS, Gwizdala CJ (1981) Evaluation of toxic serum theophylline concentrations. Am J Hosp Pharm 38: 1164–1166
Mangione A, Imhof TE, Lee RV, Shum LY, Jusko WJ (1978) Pharmacokinetics of theophylline in hepatic disease. Chest 73: 616–622
Jonkman JHG, Upton RA (1984) Pharmacokinetic drug interactions with theophylline. Clin Pharmacokinet 9: 309–334
Manfredi RF, Vesell ES (1981) Inhibition of theophylline metabolism by long-term allopurinol administration. Clin Pharmacol Ther 29: 224–229
Jackson JE, Powell JR, Wandell M, Bentley J, Dorr R (1981) Cimetidine decreases theophylline clearance. Am Rev Resp Dis 123: 615–617
Laforce C, Miller M, Chai H (1981) Effect of erythromycin on theophylline clearance in asthmatic children. J Pediatr 99: 153–156
Wijnands WJA, Vree TB, Van Herwaarden CLA (1985) Enoxacin decrease the clearance of theophylline in man. Br J Clin Pharmacol 20: 583–588
Wijnands WJA, Vree TB, Van Herwaarden CLA (1986) The influence of quinolone derivatives on theophylline clearance. Br J Clin Pharmacol 22: 677–683
Ogura Y, Hasegawa T, Yokochi Y, Yamada S, Kitazawa S, Takagi K (1983) Clinical application of substrate-labeled fluorescent immunoassay with antiserum produced using 9-theophylline-BSA immunogen. Jpn J Hosp Pharmacol 9: 260–266
Yasuda K, Tsurumi K Fujimura H (1986) Study of drug interaction between the new antiallergic drug 11-oxo-11H-pyrido[2,1-b]quinazoline-2-carboxylic acid and theophylline. Arzneimittelforsch 36: 1642–1646
Asamoto H, Kokura M, Kawakami A, Sasaki Y, Fujii H, Sawano N, Ohara Y, Kitamura Y, Morishita H (1988) Effect of azelastine on theophylline clearance in asthma patients. Jpn J Allergol 37: 1033–1037
Matejeck M, Irwin P, Neff G, Abt K, Wehrli W (1985) Determination of the central effects of the asthma prophylactic ketotifen, the bronchodilator theophylline and both in combination. An application of quantitative electroencephalography to the study of drug interactions. Int J Clin Pharmacol Ther Toxicol 23: 258–266
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takagi, K., Kuzuya, T., Horiuchi, T. et al. Lack of effect of repirinast on the pharmacokinetics of theophylline in asthmatic patients. Eur J Clin Pharmacol 37, 301–303 (1989). https://doi.org/10.1007/BF00679789
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00679789